相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells
Rodolfo B. Serafim et al.
CANCER GENE THERAPY (2020)
Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 signaling
Chen-jing Wang et al.
CELL DEATH & DISEASE (2020)
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
Winifred Lo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
Lynda Vuong et al.
CANCER DISCOVERY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions
Aly-Khan A. Lalani et al.
EUROPEAN UROLOGY (2019)
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
Scott J. Rodig et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways
Tianchi Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Jan A. Burger et al.
NATURE REVIEWS CANCER (2018)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop
Rui Cao et al.
JOURNAL OF CANCER (2017)
Gene expression markers of Tumor Infiltrating Leukocytes
Patrick Danaher et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors
Nathan O. Siemers et al.
PLOS ONE (2017)
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy (vol 28, pg 44, 2017)
A. R. Sanchez-Paulete et al.
ANNALS OF ONCOLOGY (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
What next for treatment?
Robert J. Motzer
NATURE (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The role of tumour-associated macrophages in bone metastasis
Sofia Sousa et al.
JOURNAL OF BONE ONCOLOGY (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Systematic pan-cancer analysis of tumour purity
Dvir Aran et al.
NATURE COMMUNICATIONS (2015)
HJURP Involvement in De Novo CenH3CENP-A and CENP-C Recruitment
Hiroaki Tachiwana et al.
CELL REPORTS (2015)
Immune signature of tumor infiltrating immune cells in renal cancer
Katharina Geissler et al.
ONCOIMMUNOLOGY (2015)
Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I
Aude G. Chapuis et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Inhibition of the mTOR pathway: A possible protective role in coronary artery disease
Giovanni Tarantino et al.
ANNALS OF MEDICINE (2013)
Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics
W. Marston Linehan
GENOME RESEARCH (2012)
Depletion of Plasmacytoid Dendritic Cells Inhibits Tumor Growth and Prevents Bone Metastasis of Breast Cancer Cells
Anandi Sawant et al.
JOURNAL OF IMMUNOLOGY (2012)
Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options
Giuseppe Pignataro et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Renal Cell Carcinoma Preface
Toni K. Choueiri
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
Elaine M. Dunleavy et al.
CELL (2009)
Centromere-Specific Assembly of CENP-A Nucleosomes Is Mediated by HJURP
Daniel R. Foltz et al.
CELL (2009)
Activation of holliday junction-recognizing protein involved in the chromosomal stability and immortality of cancer cells
Tatsuya Kato et al.
CANCER RESEARCH (2007)
Current development of mTOR inhibitors as anticancer agents
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Renal-cell carcinoma
HT Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mammalian target of rapamycin inhibition as therapy for hematologic malignancies
A Panwalkar et al.
CANCER (2004)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)